MA-CHAOSSEARCH
Today, ChaosSearch, a leader in data analytics, announced the integration of Chaos LakeDB with Amazon Bedrock from Amazon Web Services (AWS), a fully managed service that makes foundation models (FMs) from leading AI companies accessible via an API to build and scale generative AI applications. This integration is designed to transform the way organizations leverage generative artificial intelligence (AI) to interact with their unified data lakes for observability, security lakes, and application insight use cases, providing clients with enhanced simplicity, choice, and security. Chaos LakeDB customers can select any large language model (LLM) from Amazon Bedrock’s choice of high-performing FMs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231127237186/en/
The combination of generative AI and ChaosSearch’s unified data lake offers new possibilities for enterprises. Chaos LakeDB opens these opportunities while delivering cost-effective scaling and simplifying working with data pipelines, data preparation, and data islands. It integrates with and orchestrates pre-trained generative AI models as a complement to Search and SQL analytics, creating an ideal launch point for enterprises to immediately realize efficiency improvements across observability, security lake, and application insight use cases.
"As a long-term partner with ChaosSearch, we've witnessed firsthand the transformative impact of their technology on our data analytics capabilities," said Jimmy McDermott of PATHWAYos. "The integration of Chaos LakeDB with Amazon Bedrock represents a leap forward in our ability to harness the full power of generative AI within our data strategy. The seamless and secure interaction with LLMs has allowed us to tap into a new dimension of data intelligence, optimizing our workflows, and enhancing our decision-making process. ChaosSearch's vision for the future of data interaction is not just a promise; it's a reality that's delivering exceptional value to our organization."
Chaos LakeDB integration with Amazon Bedrock allows users to engage with their data through a conversational AI interface, leveraging public and private LLM models. By utilizing prompt engineering and orchestrating chain-of-thought interaction, users can converse directly with their data with enhanced security. The integration leverages AWS’s data security and privacy best practices and no confidential or proprietary data is shared with the LLM. Furthermore, this design removes the challenges of complex and costly model training while preventing data hallucinations.
With the integration of Chaos LakeDB with Amazon Bedrock, organizations can further isolate their data in a private workspace where all exchanges of information between the database and the LLM are private. None of the customer’s data is used to train or fine-tune the underlying LLM. In essence, the LLM is private to the user account.
Chaos LakeDB’s integration with Amazon Bedrock delivers:
- Intuitive Data Exploration: Understand complex data effortlessly with ChaosSearch AI Assistant's ability to suggest, process queries, and surface crucial insights, eliminating the barrier of advanced analytical skills.
- Code Co-pilot: Receive smart support for writing and refining Elastic and SQL queries, with the assurance of secure processing.
- Enhanced Team Collaboration: Promote efficient teamwork and shared understanding through user-friendly data sharing and exploration tools, suitable for various expertise levels.
- Immediate Insights: Obtain real-time visibility into key operational areas such as system behavior, security monitoring, and application performance.
"AI is transforming business intelligence," said Dr. Sherry Marcus, director of Applied Science of Amazon Bedrock and Amazon Titan at Amazon Web Services. "The Chaos LakeDB integration with Amazon Bedrock is simplifying how customers engage with and analyze their data—and with the security and scalability that enterprises demand. Using conversational queries to interact with their data, customers will be able to glean deeper insights and make more informed decisions. We look forward to seeing how the power of generative AI will enhance customers’ business strategies."
"At ChaosSearch, we are deeply passionate about empowering our clients to conquer the ever-growing mountain of data analytics challenges," said Thomas Hazel, founder and CTO of ChaosSearch. "The integration of Chaos LakeDB with Amazon Bedrock is a critical milestone on our ambitious roadmap. It's designed to provide a straightforward, high-impact entry point for organizations embarking on their generative AI journey. We're not just enhancing our platform; we're providing a key that unlocks high-value insights while simplifying the journey to scale analytics. Our dedication to innovation is relentless, and this integration exemplifies our commitment to delivering not just solutions but pathways to transformation and growth that redefine analytics at scale for our clients."
An innovative solution for data interaction and analysis, Chaos LakeDB's integration with Amazon Bedrock is a powerful tool for businesses worldwide. As the company moves forward with its dynamic roadmap, clients can anticipate even more advanced features and capabilities tailored to their specific needs. As clients look to train their own models or augment existing FMs, Chaos LakeDB will play a critical role for creation, test data access and exporting for training and deploying generative AI models in production at scale without breaking the bank.
Chaos LakeDB and the integration with Amazon Bedrock is available in early access. Contact us, for more information or to request a demo.
About ChaosSearch:
ChaosSearch is redefining the boundaries of data analytics by offering transformative solutions that empower businesses to make data-driven decisions with unparalleled efficiency. Our ethos is centered on simplifying complexity and turning challenges into opportunities. Chaos LakeDB is at the forefront of revolutionizing data lake architectures in the AI-driven era. By seamlessly transforming cloud storage into a dynamic analytical database, it integrates diverse data streams, streamlines intricate pipelines, and delivers at scale actionable insights through Search+SQL+GenAI analytics. By eliminating manual redundancies and activating static data lakes, Chaos LakeDB provides businesses with both real-time and historical intelligence. As champions of innovation, ChaosSearch is dedicated to delivering tools that not only meet but also anticipate the evolving needs of modern businesses. Dive into a world where data is not just stored but becomes a dynamic force driving growth and innovation.
Leading cloud-based organizations, including Equifax, Cisco, Revinate, and Digital River, trust the ChaosSearch Cloud Data Platform. For more information, visit ChaosSearch.io or follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231127237186/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 13:00:00 CEST | Press release
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 13:00:00 CEST | Press release
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expe
Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania2.6.2025 12:30:00 CEST | Press release
Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama $2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025 Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, North, and Tembo zones and is based on the December 2024 Mineral Resource Update (refer to Lifezone’s December 5, 2024 news
Corpay Cross-Border Named an Official Partner of Real Madrid C.F.2.6.2025 12:00:00 CEST | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real Madrid, one of the world’s most widely recognized and followed sports franchises," said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “With our strong focus on growing the Corpay brand, as well as our currency risk management business, we are excited to partner with one of the most successful football clubs in the world.” About Corpay Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments co
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 20252.6.2025 12:00:00 CEST | Press release
Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitorData underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure. “Presenting the first clinical data for two novel breast cancer candidates at ASCO 2025 marks a pivotal moment for BeOne,” said Mark Lanas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom